A feasibility study of dosimetry for breast cancer radiotherapy based on body surface changes.

Abstract

The requirement for precise and effective delivery of the actual dose to the patient grows along with the complexity of breast cancer radiotherapy. Dosimetry during treatment has become a crucial component of guaranteeing the efficacy and security. To propose a dosimetry method during breast cancer radiotherapy based on body surface changes. A total of 29 left breast cancer radiotherapy cases were retroactively retrieved from an earlier database for analysis. Non-rigid image registration and dose recalculation of the planning computed tomography (CT) referring to the Cone-beam computed tomography were performed to obtain dose changes. The study used 3D point cloud feature extraction to characterize body surface changes. Based on the correlation proof, a mapping model is developed between body surface changes and dose changes using neural network framework. The MSE metrics, the Euclidean distances of feature points and the 3D gamma pass rate metric were used to assess the prediction accuracy. A strong correlation exist between body surface changes and dose changes (first canonical correlation coefficient=0.950). For the dose deformation field and dose amplitude difference in the test set, the MSE of the predicted and actual values were 0.136 pixels and 0.229 cGy, respectively. After deforming the planning dose into a deformed one, the feature points' Euclidean distance between it and the recalculated dose changes from 9.267±1.879mm to 0.456±0.374mm. The 3D gamma pass rate of 90% or higher for the 2mm/2% criteria were achieved by 80.8% of all cases, with a minimum pass rate of 75.9% and a maximum pass rate of 99.6%. Pass rate for the 3mm/2% criteria ranged from 87.8% to 99.8%, with 92.3% of the cases having a pass rate of 90% or higher. This study provides a dosimetry method that is non-invasive, real-time, and requires no additional dose for breast cancer radiotherapy.